![Oncolytics Biotech Inc. logo](/logos/ONCY.webp)
Oncolytics Biotech Inc.
NASDAQ:ONCY
Overview | Financials
Company Name | Oncolytics Biotech Inc. |
Symbol | ONCY |
Currency | USD |
Price | 0.958 |
Market Cap | 73,752,588 |
Dividend Yield | 0% |
52-week-range | 0.85 - 2.35 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Matthew C. Coffey M.B.A., Ph.D. |
Website | https://www.oncolyticsbiotech.com |
An error occurred while fetching data.
About Oncolytics Biotech Inc.
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD